About Life Molecular Imaging
Life Molecular Imaging is a Healthcare company based in Berlingerode (Germany) founded in 2012, and was acquired by Lantheus in January 2025. PET tracers for neurodegenerative and cardiovascular diagnostics are developed. Its chief executive, as recorded, is Ludger Dinkelborg. Its focus areas include Clinical Laboratories and Radiology. Its legal entity is Life Molecular Imaging Ltd.
Company details
Life Molecular Imaging was founded in 2012 in Berlingerode, Germany, within the radiopharmaceutical sector. Novel PET tracers are developed and commercialized for molecular imaging applications. Focus is placed on early detection and characterization of neurodegenerative and cardiovascular diseases. The lead product supports Alzheimers diagnosis, while the research portfolio includes tracers for additional neurodegenerative conditions. Operations aim to enhance disease management through improved imaging tools.
- Headquarters Berlingerode, Germany
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website life-mi.com
- Social LinkedIn
- Acquired by Lantheus (Jan 2025)
- Legal Name Life Molecular Imaging Ltd
Investors in Life Molecular Imaging
Life Molecular Imaging has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Lantheus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Developer of diagnostic imaging agents and targeted therapeutics | 2008 | lantheus.com | Billerica, United States |
Investor details for Life Molecular Imaging
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Life Molecular Imaging
31 people are tracked at Life Molecular Imaging (13 in leadership, 18 in team).
| Name | Role | Group |
|---|---|---|
Ludger Dinkelborg | CEO & MD | Leadership |
Richard Keegan | Director Of Medical Affairs | Leadership |
Matthew Trifilo | Vice President, Head Of Medical Affairs | Leadership |
Natalia Verónica Henriquez Gonzalez | Head Of QMS And GDP | Leadership |
Norman Koglin | Head Of Scientific Operations | Leadership |
Andre Mueller | Head Clinical & Preclinical R&d | Leadership |
Caroline Papin | Head Of Analytical Development | Leadership |
Andrew Stephens | Chief Medical Officer | Leadership |
Clemens Mahnecke | Head Of QA Management US | Leadership |
Michel Jongens | Chief Financial Officer | Leadership |
Mathias Berndt | Chief Technology Officer | Leadership |
Nico Beukman | Chief Commercial Officer: Europe, Middle East And Africa | Leadership |
Michelle Deridder | Head Of Marketing | Leadership |
Steven Kopcho | Medical Science Liason | Team |
Beatriz Blanco Rodriguez | Global Regulatory Affairs & Pharmacovigilance Manager | Team |
Eva-Maria Bickel | R&d Engineer | Team |
Ramya Suresh | Business Analyst | Team |
Chris Bentley | Key Account Manager | Team |
Aleksandar Jovalekic | Clinical Development Manager | Team |
Rohit Malik | Accountant Ap/ar/treasury | Team |
11 more people are available in the full profile.
Complete people profiles for Life Molecular Imaging
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Life Molecular Imaging
2 dated milestones of Life Molecular Imaging across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Life Molecular Imaging is founded.
- Exit Acquired by Lantheus.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Life Molecular Imaging
Complete news archive for Life Molecular Imaging
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Life Molecular Imaging
Life Molecular Imaging was founded in 2012.
Life Molecular Imaging is headquartered in Berlingerode, Germany. It is registered at Berlingerode, Thuringen, Germany.
Ludger Dinkelborg is the CEO of Life Molecular Imaging, as recorded in our data.
Life Molecular Imaging was founded in 2012 in Berlingerode, Germany, within the radiopharmaceutical sector. Novel PET tracers are developed and commercialized for molecular imaging applications. Focus is placed on early detection and characterization of neurodegenerative and cardiovascular diseases. The lead product supports Alzheimers diagnosis, while the research portfolio includes tracers for additional neurodegenerative conditions. Operations aim to enhance disease management through improved imaging tools.
Life Molecular Imaging has 1 investor. Key investors include Lantheus.
Life Molecular Imaging operates through Life Molecular Imaging Ltd.
Yes. Life Molecular Imaging was acquired by Lantheus in January 2025.